The importance of reaching lipid targets: statins and the prevention of atherosclerosis
- PMID: 12846345
The importance of reaching lipid targets: statins and the prevention of atherosclerosis
Abstract
To help prevent the development of coronary heart disease (CHD), the European and NCEP guidelines have recommended target cholesterol levels for all individuals. Lifestyle changes are advocated for individuals not achieving these targets. Intervention with lipid-modifying agents may be required for patients at high risk of a cardiovascular event and statins are generally recognised as first-line therapy. Unfortunately, large numbers of patients at risk of cardiovascular events are not being treated to the guideline targets. Primary care physicians are in a good position to improve lipid management by assessing risk factors, implementing lipid management strategies, monitoring whether targets are being reached and amending treatment appropriately. Furthermore, by educating and motivating patients,primary care physicians may improve compliance with lifestyle changes and medication. These approaches may help more patients to achieve recommended lipid levels and prevent the development of cardiovascular disease.
Similar articles
-
Achieving vascular risk factor targets: a survey of a London general practice.Angiology. 2008 Feb-Mar;59(1):36-46. doi: 10.1177/0003319707309538. Angiology. 2008. PMID: 18319220
-
Guideline-oriented ambulatory lipid-lowering therapy of patients at high risk for cardiovascular events by cardiologists in clinical practice: the 2L cardio registry.Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):438-44. doi: 10.1097/HJR.0b013e32832a4e25. Eur J Cardiovasc Prev Rehabil. 2009. PMID: 19369876
-
Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.Clin Ther. 2004 Nov;26(11):1821-33. doi: 10.1016/j.clinthera.2004.11.015. Clin Ther. 2004. PMID: 15639694 Clinical Trial.
-
Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe.Curr Med Res Opin. 2006 Mar;22(3):511-28. doi: 10.1185/030079906X89856. Curr Med Res Opin. 2006. PMID: 16574035 Review.
-
Risk factor management: antiatherogenic therapies.Eur J Cardiovasc Prev Rehabil. 2009 Aug;16 Suppl 2:S29-36. doi: 10.1097/01.hjr.0000359233.58023.64. Eur J Cardiovasc Prev Rehabil. 2009. PMID: 19675434 Review.
Cited by
-
ACE inhibitors in patients with vascular disease: should the PEACE trial change medical practice?Curr Hypertens Rep. 2005 Apr;7(2):119-20. doi: 10.1007/s11906-005-0084-2. Curr Hypertens Rep. 2005. PMID: 15748535 Clinical Trial. No abstract available.
-
Plasma cholesterol and related lipid levels of seemingly healthy public service employees in Kampala, Uganda.Afr Health Sci. 2006 Sep;6(3):139-44. doi: 10.5555/afhs.2006.6.3.139. Afr Health Sci. 2006. PMID: 17140334 Free PMC article.
-
Trends in total cholesterol screening and in prescribing lipid-lowering drugs in general practice in the period 1994-2003.BMC Fam Pract. 2008 Jun 30;9:39. doi: 10.1186/1471-2296-9-39. BMC Fam Pract. 2008. PMID: 18590552 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical